$485 Million is the total value of Meditor Group Ltd's 6 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EXEL | EXELIXIS INC | $314,051,000 | +11.0% | 15,966,038 | 0.0% | 64.69% | +6.4% | |
ESPR | Buy | ESPERION THERAPEUTICS INC | $123,272,000 | +5.6% | 2,679,835 | +1.9% | 25.39% | +1.2% |
ALKS | Sell | ALKERMES PLC | $26,334,000 | -39.8% | 892,400 | -13.4% | 5.42% | -42.3% |
INDA | Buy | ISHARES MSCI INDIA ETF | $10,646,000 | +13.1% | 320,000 | +10.3% | 2.19% | +8.3% |
EPI | WISDOMTREE INDIA EARNINGS FUND | $9,920,000 | +2.9% | 400,000 | 0.0% | 2.04% | -1.4% | |
CLDX | CELLDEX THERAPEUTICS | $1,249,000 | -56.1% | 6,312,700 | 0.0% | 0.26% | -58.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-01-02
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
EXELIXIS INC | 43 | Q4 2023 | 88.9% |
ALKERMES PLC | 31 | Q4 2020 | 62.6% |
ISHARES MSCI INDIA ETF | 31 | Q4 2023 | 5.5% |
WISDOMTREE INDIA EARNINGS FUND | 31 | Q4 2023 | 5.5% |
ESPERION THERAPEUTICS INC | 27 | Q4 2023 | 34.4% |
VIVUS INC | 15 | Q4 2016 | 21.3% |
CELLDEX THERAPEUTICS | 14 | Q2 2020 | 2.7% |
PROSHARES ULTRAPRO SHORT S&P500 | 4 | Q4 2017 | 3.8% |
PROSHARES ULTRASHORT S&P500 | 4 | Q4 2017 | 3.0% |
PROSHARES ULTRASHORT S&P 500 ETF | 3 | Q3 2019 | 0.8% |
View Meditor Group Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
EXELIXIS, INC. | April 09, 2019 | 15,001,073 | 5.0% |
VIVUS INC | December 19, 2012 | 5,002,896 | 5.0% |
VIVUS INC | March 21, 2012 | 6,177,500 | 6.3% |
VION PHARMACEUTICALS INC | February 15, 2008 | 5,736,200 | 7.6% |
CYPRESS BIOSCIENCE INC | September 26, 2007 | 1,864,645 | 5.0% |
ONYX PHARMACEUTICALS INC | September 12, 2007 | 2,627,800 | 4.8% |
ACUSPHERE INC | July 26, 2007 | 1,839,421 | 4.0% |
NOVACEA INC | June 11, 2007 | 800,000 | 3.4% |
ATHEROGENICS INC | May 02, 2007 | 1,361,800 | 3.5% |
View Meditor Group Ltd's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-01-04 |
SC 13G/A | 2024-01-03 |
13F-HR | 2023-10-31 |
13F-HR | 2023-07-25 |
13F-HR | 2023-04-10 |
13F-HR | 2023-01-05 |
SC 13G/A | 2023-01-04 |
13F-HR | 2022-11-07 |
13F-HR | 2022-07-18 |
13F-HR | 2022-04-12 |
View Meditor Group Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.